J.-L. Lagrange

760 total citations
15 papers, 595 citations indexed

About

J.-L. Lagrange is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, J.-L. Lagrange has authored 15 papers receiving a total of 595 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 5 papers in Surgery and 4 papers in Oncology. Recurrent topics in J.-L. Lagrange's work include Prostate Cancer Diagnosis and Treatment (3 papers), Brain Metastases and Treatment (3 papers) and Management of metastatic bone disease (3 papers). J.-L. Lagrange is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (3 papers), Brain Metastases and Treatment (3 papers) and Management of metastatic bone disease (3 papers). J.-L. Lagrange collaborates with scholars based in France. J.-L. Lagrange's co-authors include A. Thyss, M Schneider, M C Etienne, F Démard, O. Dassonville, Ronald A. Fleming, N. Renée, G. Milano, A. Laplanche and C. Tuchais and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics and Radiotherapy and Oncology.

In The Last Decade

J.-L. Lagrange

15 papers receiving 579 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J.-L. Lagrange France	8	375	227	146	132	77	15	595
Anthea Lau Canada	9	158 0.4×	154 0.7×	57 0.4×	127 1.0×	36 0.5×	28	413
Benjamin C. Garden United States	7	290 0.8×	109 0.5×	106 0.7×	44 0.3×	79 1.0×	13	547
A.N. Harnett United Kingdom	12	241 0.6×	69 0.3×	89 0.6×	22 0.2×	83 1.1×	31	486
Henning Bredenfeld Germany	14	380 1.0×	222 1.0×	66 0.5×	130 1.0×	38 0.5×	22	833
Xiao-Jing Du China	8	497 1.3×	194 0.9×	67 0.5×	43 0.3×	145 1.9×	9	677
Haruhito Kamei Japan	9	389 1.0×	465 2.0×	53 0.4×	22 0.2×	66 0.9×	37	573
Noriko Ii Japan	13	146 0.4×	200 0.9×	47 0.3×	49 0.4×	185 2.4×	40	519
Nicolas Dickgreber Germany	11	318 0.8×	429 1.9×	134 0.9×	32 0.2×	76 1.0×	31	585
Hsing‐Lung Chao Taiwan	17	200 0.5×	283 1.2×	62 0.4×	40 0.3×	291 3.8×	36	764
L. Trodella Italy	14	353 0.9×	469 2.1×	32 0.2×	122 0.9×	192 2.5×	58	826

Countries citing papers authored by J.-L. Lagrange

Since Specialization

Citations

This map shows the geographic impact of J.-L. Lagrange's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.-L. Lagrange with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.-L. Lagrange more than expected).

Fields of papers citing papers by J.-L. Lagrange

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.-L. Lagrange. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.-L. Lagrange. The network helps show where J.-L. Lagrange may publish in the future.

Co-authorship network of co-authors of J.-L. Lagrange

This figure shows the co-authorship network connecting the top 25 collaborators of J.-L. Lagrange. A scholar is included among the top collaborators of J.-L. Lagrange based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.-L. Lagrange. J.-L. Lagrange is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Thureau, S., et al.. (2021). Radiotherapy of bone metastases. Cancer/Radiothérapie. 26(1-2). 368–376. 4 indexed citations

Pissard, Serge, Anoosha Habibi, D. Bachir, et al.. (2015). Hématopoïèse extra-médullaire symptomatique au cours des β-thalassémies : étude rétrospective monocentrique. La Revue de Médecine Interne. 37(1). 5–12. 2 indexed citations

Thureau, S., et al.. (2015). Quels fractionnements en radiothérapie des métastases osseuses ?. Cancer/Radiothérapie. 19(6-7). 437–441. 2 indexed citations

Guérif, S., I. Latorzeff, J.-L. Lagrange, et al.. (2014). Radiothérapie postopératoire des cancers de la prostate. Cancer/Radiothérapie. 18(5-6). 517–523. 5 indexed citations

Crevoisier, R. de, J. Castelli, S. Guérif, et al.. (2014). Cancers de prostate : quelles techniques de radiothérapie pour quelles tumeurs ? Enjeux éthiques et méthodologiques. Cancer/Radiothérapie. 18(5-6). 369–378. 8 indexed citations

Pommier, P., Magali Morelle, Lionel Perrier, et al.. (2012). Évaluation économique prospective de la radiothérapie guidée par l’image des cancers de la prostate dans le cadre du programme national de soutien aux thérapeutiques innovantes et coûteuses. Cancer/Radiothérapie. 16(5-6). 444–451. 13 indexed citations

Pouessel, Damien, Juliette Thariat, J.-L. Lagrange, Nicolas Mottet, & Stéphane Culine. (2010). Stratégies périopératoires dans les carcinomes urothéliaux de vessie infiltrant le muscle. Bulletin du Cancer. 97(3). S5–S9. 1 indexed citations

Drouet, Franck & J.-L. Lagrange. (2010). Dose de tolérance à l’irradiation des tissus sains : la moelle osseuse. Cancer/Radiothérapie. 14(4-5). 392–404. 11 indexed citations

Lagrange, J.-L., et al.. (2005). [Role of the combination of external radiotherapy--partial cystectomy--interstitial brachytherapy in pT1 G3, pT2 and pT3 bladder tumors].. PubMed. 39 Suppl 5. S104–12. 3 indexed citations

10.

Etienne, M C, J.-L. Lagrange, O. Dassonville, et al.. (1994). Population study of dihydropyrimidine dehydrogenase in cancer patients.. Journal of Clinical Oncology. 12(11). 2248–2253. 348 indexed citations

11.

Haie‐Méder, Christine, B. Pellae-Cosset, A. Laplanche, et al.. (1993). Results of a randomized clinical trial comparing two radiation schedules in the palliative treatment of brain metastases. Radiotherapy and Oncology. 26(2). 111–116. 86 indexed citations

12.

Carrié, C., Claire Alapetite, H Kolodié, et al.. (1992). Quality control of radiotherapeutic treatment of medulloblastoma in a multicentric study: The contribution of radiotherapy technique to tumour relapse. Radiotherapy and Oncology. 24(2). 77–81. 77 indexed citations

13.

Malissard, L, T.D. Nguyen, Geena Jung, et al.. (1991). Localized adenocarcinoma of the lung: A retrospective study of 186 non-metastatic patients from the french federation of cancer institutes—the radiotherapy cooperative group. International Journal of Radiation Oncology*Biology*Physics. 21(2). 369–373. 15 indexed citations

14.

Riviére, A., P. Berthaud, M. Frénay, et al.. (1989). [Results of a phase II study of the combination of cis-platinum and 5-FU in epidermoid or undifferentiated large cell bronchial cancer].. PubMed. 76(10). 1095–102. 4 indexed citations

15.

Lagrange, J.-L., et al.. (1988). Toxicity of a combination of ABVD chemotherapy and mediastinal irradiation for Hodgkin's disease patients with massive initial mediastinal involvement.. PubMed. 75(8). 801–6. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact